Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests

Dermatology

Volumn 213, Issue 1, 2006, Pages 40-43

  Buettiker, U ^a   Keller, M ^a   Pichler, W J ^a   Braathen, L R ^a   Yawalkar, N ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute generalized exanthematous pustulosis; Lymphocyte transformation test; Patch test; Prednisolone; Pustulosis

Indexed keywords

BETAMETHASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISOLONE TETRAHYDROPHTHALATE; TIXOCORTOL PIVALATE; UNCLASSIFIED DRUG;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE EXACERBATION; DRUG ERUPTION; ECZEMA; FEVER; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE TRANSFORMATION TEST; MALAISE; MALE; NEUTROPHILIA; PATCH TEST; PRIORITY JOURNAL; PUSTULE; SKIN SENSITIZATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; EXANTHEMA; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PREDNISOLONE;

EID: 33745203328     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092837     Document Type: Article

References (20)

1. Roujeau JC, Bioulac-Sage P, Bourseau C, et al: Acute generalized exanthematic pustulosis: analysis of 63 cases. Arch Dermatol 1991;127:1333-1338.
2. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC: Acute generalized exanthematic pustulosis (AGEP) - A clinic reaction pattern. J Cutan Pathol 2001;28:113-119.
3. Saissi EH, Beau-Salinas F, Jonville-Bera AP: Centres Régionaux de Pharmacovigilance: drugs associated with acute generalized exanthematic pustulosis. Ann Dermatol Vénéréol 2003;130:612-618.
4. Yawalkar N, Hari Y, Helbing A, von Greyerz S, Kappeler A, Braathen LR, Pichler WJ: Elevated serum levels of interleukins 5, 6 and 10 in a patient with drug-induced exanthem caused by systemic corticosteroids. J Am Acad Dermatol 1998;39:790-793.
5. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-820.
6. Dooms-Goossens A, Andersen KE, Brandao FM, Bruynzeel D, Burrows D, Camarasa J, Ducombs G, Frosch P, Hannuksela M, Lachapelle JM, Lahti A, Menné T, Wahlberg JE, Wilkinson JD: Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis 1996;35:40-44.
7. Coopman S, Drieghe J, Dooms-Goossens A: Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 1994;19:1-11.
8. Matura M, Goossens A: Contact allergy to corticosteroids. Allergy 2000;55:698-704.
9. Bircher AJ, Levy F, Langauer S, Lepoittevin JP: Contact allergy to topical corticosteroids and systemic contact dermatitis from prednisolone with tolerance of triamcinolone. Acta Derm Venereol 1995;75:490-493.
10. Mussot-Chia C, Flechet ML, Napolitano M, et al: Methylprednisolone- induced acute generalized exanthematous pustulosis. Ann Dermatol Venereol 2001;128:241-243.
11. Demitsu T, Kosuge A, Yamada T: Acute generalized exanthematous pustulosis induced by dexamethasone injection. Dermatology 1996;193:56-58.
12. Wolkenstein P, Chosidow O, Fléchet ML, et al: Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996;35:234-236.
13. Hausermann P, Scherer K, Weber M, Bircher AJ: Ciprofloxacin-induced acute generalized exanthematous pustulosis mimicking bullous drug eruption confirmed by a positive patch test. Dermatology 2005;211:277-280.
14. Anliker MD, Wuthrich B: Acute generalized exanthematous pustulosis due to sulfamethoxazol with positive lymphocyte transformation test (LTT). J Investig Allergol Clin Immunol 2003;13:66-68.
15. Trueb RM, Burg G: Acute generalized exanthematous pustulosis due to doxycycline. Dermatology 1993;186:75-78.
16. Rogalski C, Hurliman A, Burg G, et al: Terbinafine-induced acute generalized exanthematous pustulosis. Hautarzt 2001;52:444-448.
17. Goeschke B, Braathen LR: Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology 2004;209:53-56.
18. Britschgi M, Steiner UC, Schmid S, et al: T-cell involvement in drug-induced generalized exanthematic pustulosis. J Clin Invest 2001;107:1433-1441.
19. Schmid S, Kuechler PC, Britschgi M, et al: Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 2002;161:2079-2086.
20. Pichler WJ: Immune mechanism of drug hypersensitivity. Immunol Allergy Clin North Am 2004;24:373-397.